Partner Therapeutics
PrivateLast Round
Grant
Feb 17, 2022
Total Funding Raised
$100M
Company Overview
Partner Therapeutics operates in Healthcare & Life Sciences and is based in Lexington, Massachusetts. Its latest recorded funding round was a Grant round in February 2022.
Partner Therapeutics is a biopharmaceutical company that develops and commercializes therapies for cancer and other serious diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Partner Therapeutics Comparables
Compare Partner Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Genmab A/S | 85% | |
| Amgen | 77% | |
| Teva Pharmaceuticals | 76% |
For institutional investors. Book with your work email.
Partner Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Feb 17, 2022 | ||||
| Grant | Aug 4, 2020 | ||||
| Series A | Feb 1, 2018 |
For institutional investors. Book with your work email.
Partner Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Perceptive Advisors | Series A |
| U.S. Department of War | Grant |
| Adams Street Partners | Series A |
| MidCap Financial | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 11, 2025
Monthly visitors increased 72% MoM.
- Jan 25, 2025
Monthly visitors grew 167% MoM, reaching 4K.
For institutional investors. Book with your work email.
Partner Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Partner Therapeutics's valuation, stock price, and market status.
Is Partner Therapeutics a public or private company?
Partner Therapeutics is a private company.
What is the current stock price of Partner Therapeutics?
Partner Therapeutics is a private company, so its shares have no public market price. Caplight tracks Partner Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Partner Therapeutics worth (valuation)?
Valuation information for Partner Therapeutics is not publicly available.
Can I buy Partner Therapeutics stock?
Partner Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Partner Therapeutics's last funding round?
Partner Therapeutics's most recent funding round was Grant on February 17, 2022.
Who are the main investors in Partner Therapeutics?
Key investors in Partner Therapeutics include Perceptive Advisors.
Will Partner Therapeutics IPO soon?
No public IPO plans have been announced for Partner Therapeutics.
How can I track Partner Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Partner Therapeutics's shares on secondary markets.